Long-Term Efficacy of Semi-Synthetic Human Insulins (SHI) in Newly-Diagnosed Insulin-Dependent Diabetic Patients. A Two Year Clinical Study

References

• Schlichtkrull J: Purity and antigenicity of insulin preparations. Acta Paecl Scand. 1977; 270 (Suppl. 1): 37–40.
   Google Scholar
• Schlichtkrull J: Insulin in perspective. IDF Bulletin. 1979; 24: 7–10.
   Google Scholar
• Markusscn J, Damgaard U, Pingcl M, Sncl L, Srcnscn A R. Srcnscn E: Human Insulin (NOVO): Chemistry and characteristics. Diabetes Care. 1983;-(Suppl. 1): 4–8.
   Google Scholar
• Owens D R, Volund A, Alberti K G M M, Home P D: A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponcnt insulin in non-diabetic subjects. Diab Metab. 1982; 8: 155–8.
   Google Scholar
• Ebihara A, Kondo K. Ohashi K, Kosaka K, Kuruya T, Matsuda A: Comparative clinical pharmacology of human insulin (NOVO) and porcine insulin in normal subjects. Diabetes Care. 1983; 6: (Suppl. 1): 17–22.
   Google Scholar
• Lyngse J, Vcstcrmark S: The efficacy of safety of human insulin (NOVO) in insulindependent diabetic patients. Diabetes Care. 1983; 6 (Suppl. 1): 53–5.
   Google Scholar
• Karam J, Brink S, Clements R, Miller L, Raskin P: Evaluation of efficacy and safety of human insulin (NOVO) in the treatment of insulin-dependent diabetes mellitus: a double-blind multicenter clinical trial. Diabetes Care. 1983; 6: (Suppl. 1): 56–60.
   Google Scholar
• Sestoft L, Vlund Aa, Gammaltoft S, Birch K, Hildebrandt P: The biological properties of human insulin: subcutaneous absorption, receptor binding and the clinical effect in diabctics assessed by a new statistical method. Acta Med Scand. 1982; 212: 21–28.
   Google Scholar
• Charles M A, Szekeres, A, Staten M, Worchester B, Walsh K M: Comparison of porcine insulin and human insulin (NOVO) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (NOVO) in insulin-dependent diabetes. Diabetes Care. 1983; 6 (Suppl. 1): 29–35.
   Google Scholar
• Dc Leeuw I, Abs R, Van Gaal L, Bekaert J: Efficacy and immunogenicity of semisynthetic human insulin (SHI) in newly diagnosed IDDM and patients previously treated with purified pork insulin (PPI). Diabetes. 1983; 32 (Suppl. 1): 71 (abstract).
   Google Scholar
• Schernthaner G, Borkenstcin \1, Fink M, Mayr W R, fytenzel J, Schober E: Immunogenicity of human insulin (NOBOP) or pork monocomponent insulin in HDI.-DR-types insulin-dependent diabetic individuals. Diabetes Care. 1983; 6 (Suppl. 1): 43–8.
   Google Scholar
• Kumar D: Insulin allergy: Differences in the binding of porcine, bovine and human insulins with anti-insulin IgE. Diabetes Care. 1981; 4: 104–7.
   Google Scholar
• Van de Vyver F L, Thcnaers G, De Lecuw I: Insulinrezistenz behandelt mit kontinuierlichcr intravenoser Infusion von semisynthetischcm Humaninsulin. In: Neue Insuline. Petersan KG, Schluter KJ; Kjerp L. Eds. Freiburgcr Graphische Betriebe. Freiburg, 1982: 222–6.
   Google Scholar
• Wu W, Holte M, Hcllmann N, Damon L, Grodsky G, Karam J: Superiority of human monocomponent insulin to pork monocomponent insulin in a diabetic with severe immune insulin resistance. Clin. Res. 1983; 31: 95 (abstract).
   Google Scholar
• Frankland A W: Generalised allergic reaction with synthetic human insulin. Lancet. 1982: 2: 1468.
   Google Scholar
• Fankhauscr S, Herz G, Zuppinger K: Experience avec I’insuline humaine chez des enfants diabetiqucs. Med. Hyg. (Geneve) 1982; 40: 1378–84.
   Google Scholar
• Ludvigsson J: Insulin antibodies in diabetic children treated with MC porcine insulins from the onset: relationship to B-cell function and partial remission. Diabetologia. 1984; 26: 138–41.
   Google Scholar
• Heine R J, H J G, Sikkenk A C, Vanderveen E A: Mixing short and intermediate acting insulins in the syringe: cffect on postprandial blood glucose levels in type I diabetics. Br Med J. 1985; 290: 204–5.
   Google Scholar
• Tsotsalas M, Miihlhauser, I: Mixibility of human lentc insulin with soluble insulin. Diabetologia. 1985; 28: 252 (letter).
   Google Scholar
• Bilo I1JG, Heine R J, Sikkenk A C, Van der Meer J, Vanderveen E A: Kinetics of intermediate-acting insulins: Clamp studies. Neth J Med. 1985; 28 (Suppl. 1): 55–6.
   Google Scholar
• Buysschaert M, Minette Ph, Pairct J V, Kctelslegers J M, Lambert A E: Comparison of blood glucose (BG) profile and glycemic control in type I diabetic patients treated with Actrapid HM-Monotart HM (scheme A) or Actrapid HM-Protophanc (NPH) HM (Scheme B) insulins. Diab Res Clin Pract. 1985; Suppl. 1: S79(abstract 201).
   Google Scholar